drugset / Trial / NCT01353378

Use of Dexmedetomidine in Children Undergoing Oral Maxillofacial Surgery to Decrease Emergence Delirium

NCT01353378 ↗

SequentialOpen-labelSupportive care

Summary

The purpose of this study is to determine whether dexmedetomidine is effective in the treatment of emergence delirium of preschool children undergoing oral maxillofacial surgery.

Timeline

Start
2011-06
Primary completion
2011-10
Completion
2011-12

Outcome

Outcome not reported

Stopped: “The study was not approved by Hospital's Medical Ethics Committee.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.125 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 0.25 ug/kg Intravenous

Indications